Excess Copper Chelating Therapy for Wilson Disease Induces Anemia and Liver Dysfunction

被引：11

作者：

Harada, Masaru ^{[1
]}

Miyagawa, Koichiro ^{[1
]}

Honma, Yuichi ^{[1
]}

Hiura, Masaaki ^{[1
]}

Shibata, Michihiko ^{[1
]}

Matsuhashi, Toru ^{[1
]}

Abe, Shintaro ^{[1
]}

Harada, Riko ^{[1
]}

Tabaru, Akinari ^{[1
]}

机构：

[1] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Internal Med 3, Tokyo, Japan

来源：

INTERNAL MEDICINE | 2011年 / 50卷 / 14期

关键词：

ceruloplasmin; chelating therapy; hemochromatosis; Wilson disease; ACQUIRED SIDEROBLASTIC ANEMIA; LATE ENDOSOMES; IRON; GENE; CERULOPLASMIN; ATP7B; ACERULOPLASMINEMIA; FERROPORTIN; DIAGNOSIS; HEPCIDIN;

D O I：

10.2169/internalmedicine.50.5209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 37-year-old man was diagnosed with Wilson disease at the age of 14. His first manifestations were neurological. He was treated with trientine for more than 10 years and suffered from anemia and liver dysfunction. Wilson disease is a genetic disorder characterized by accumulation of copper in the body. Excess copper is toxic, but copper is an essential trace element. Copper-binding ceruloplasmin is important for iron metabolism. Excess copper chelating treatment-induced anemia and iron deposition in the liver was suspected. Proper monitoring of copper status is important for the management of Wilson disease.

引用

页码：1461 / 1464

页数：4

共 50 条

[41] LIVER A new copper cut-off value for diagnosis of Wilson disease?
Stremmel, Wolfgang
Merle, Uta
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (09) : 493 - 494
[42] Performance of Relative Exchangeable Copper for the Diagnosis of Wilson Disease in Acute Liver Failure
Spirea, Daniela
Vanlemmens, Claire
Parant, Francois
Antonini, Teresa
Bost, Muriel
Lachaux, Alain
Belmalih, Abdelouahed
Guillaud, Olivier
Dumortier, Jerome
Couchonnal, Eduardo
JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (02)
[43] Copper metabolism after living related liver transplantation for Wilson's disease
Wang, XH
Cheng, F
Zhang, F
Li, XC
Qian, JM
Kong, LB
Zhang, H
Li, GQ
WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (12) : 2836 - 2838
[44] A single determination of liver copper concentration may misdiagnose Wilson's disease
Song, YM
Chen, MD
CLINICAL BIOCHEMISTRY, 2000, 33 (07) : 589 - 590
[45] Biological regulation of copper and selective removal of copper: Therapy for Wilson disease and its molecular mechanism
Suzuki, KT
Ogura, Y
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (10): : 899 - 908
[46] Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Roeb, Elke
VISCERAL MEDICINE, 2021, 37 (04) : 273 - 280
[47] An Unexpected Novel Antioxidant Activity for Penicillamine, a Classic Copper-Chelating Drug for the Treatment of Wilson's Disease
Zhu, Ben-Zhan
Mao, Li
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S122 - S122
[48] Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease
Poujois, Aurelia
Sobesky, Rodolphe
Meissner, Wassilios G.
Brunet, Anne-Sophie
Broussolle, Emmanuel
Laurencin, Chloe
Lion-Francois, Laurence
Guillaud, Olivier
Lachaux, Alain
Maillot, Francois
Belin, Jeremie
Salame, Ephrem
Vanlemmens, Claire
Heyd, Bruno
Bellesme, Celine
Habes, Dalila
Bureau, Christophe
Ory-Magne, Fabienne
Chaine, Pascal
Trocello, Jean-Marc
Cherqui, Daniel
Samuel, Didier
de Ledinghen, Victor
Duclos-Vallee, Jean-Charles
Woimant, France
NEUROLOGY, 2020, 94 (21) : E2189 - E2202
[49] Effect of chelation therapy in pediatric Wilson's disease: Liver and endoscopic outcome
Das, Mridul Chandra
Sen Sarma, Moinak
Srivastava, Anshu
Yachha, Surender Kumar
Poddar, Ujjal
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (04) : 336 - 345
[50] Acute liver failure with hemolytic anemia in children with Wilson's disease: Genotype-phenotype correlations?
Pop, Tudor Lucian
Grama, Alina
Stefanescu, Ana Cristina
Willheim, Claudia
Ferenci, Peter
WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1428 - 1438

← 1 2 3 4 5 →